Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-12

Clinical Trial Update: Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV [Phase 4]

View source ↗

Summary

Phase 4 trial update of alprostadil for peripheral arterial occlusive disease (Stage IV) with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALPROSTADIL (ALPROSTADIL)

Snippet

Sponsor: UCB BIOSCIENCES GmbH | Conditions: Peripheral Arterial Occlusive Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-08-12